← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2016Last known activity
Jun 3, 2019
Acquired by Novo Nordisk on Jun 11, 2020
Timeline
2010s
- Jun 1, 2014
Corvidia Therapeutics— Founded
2020s
- Jun 11, 2020
Novo Nordisk— Acquired By
Drugs by trial phase (1 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT03926117Lead sponsorPhase 2Jun 3, 2019
- NCT03126318CollaboratorPhase 1Apr 5, 2017
- NCT02868229Lead sponsorPhase 1/Phase 2Aug 1, 2016
Details
- Founded
- Waltham, MA, US Jun 1, 2014
- Last known activity
- Jun 3, 2019